On Monday, November 16, the Centers for Medicare & Medicaid Services issued a proposed rule it calls CRUSH, for Comprehensive Regulations to Uncover Suspicious Healthcare. The press release sells it as a fraud crackdown that could save taxpayers nearly $90 billion over 10 years.
The market heard something more specific.
On Wednesday, November 18, UnitedHealth fell 10.2% to $349.91. Humana fell 13% to $385.78. That was the second session after the proposal came out, and it brought the two-day drops to about 15.1% and 16.4% from Monday's closes. CVS Health, which owns Aetna, fell 5.2% to $81.35. Cigna declined 3%. UnitedHealth is one of the Dow's largest components, with a 4.32% weighting, and it dragged the index lower.
Here's the thing. The $90 billion is not a broad cleanup of fake wheelchairs and phantom hospice enrollments, even though those are the examples CMS used to sell the rule. In the agency's own impact tables, $90.2 billion is the estimated transfer from Medicare Advantage plans to the federal government if CMS extrapolates audit findings, starting with payment year 2018.
That is a Legal and Political shock to the insurers that run private Medicare. Below, I go factor by factor through what changes, and what it does to my healthcare industry analysis and insurance market SWOT.